Cyclophosphamide 500 mg/5mL (Cyclophosphamide INJECTION, SOLUTION, CONCENTRATE) 500 mg/5mL

Cyclophosphamide 500 mg/5mL is an injectable solution used for various medical conditions. This multi-dose vial is manufactured by Sandoz Inc. and is administered intravenously.

Strength

500 mg/5mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (0781-3528-10) / 5 mL in 1 VIAL, MULTI-DOSE (0781-3528-75)

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cyclophosphamide is commonly used in the treatment of certain types of cancer and autoimmune disorders. It works by interfering with the growth of cancer cells and suppressing the immune system. This medication is often prescribed by healthcare professionals for conditions that require immune system modulation or cancer treatment.

Side Effects

Common effects of Cyclophosphamide may include nausea, vomiting, and hair loss. Some individuals may experience fatigue or changes in appetite. It is important to discuss any unusual symptoms with a healthcare provider.

Precautions & Warnings

Cyclophosphamide should be handled with care, as it is a potent medication. It is essential to follow the instructions provided by a healthcare professional regarding administration and storage. This medication should not be used without proper medical supervision.

Avoid Interactions

Cyclophosphamide may interact with other medications, including certain antibiotics and vaccines. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication.

Frequently Asked Questions

Cyclophosphamide is used for treating certain types of cancer and autoimmune disorders by interfering with cell growth and suppressing the immune system.

Cyclophosphamide is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include nausea, vomiting, hair loss, fatigue, and changes in appetite.

Cyclophosphamide may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Long-term use of Cyclophosphamide should be monitored by a healthcare professional to manage potential side effects and interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.